Grad YH, Lipsitch M. Epidemiologic data and pathogen genome sequences: a powerful synergy for public health. Genome Biol. 2014 Nov 18;15(11):538. PubMed PMID: 25418119; PubMed Central PMCID: PMC4282151.

Johnson SR, Grad Y, Ganakammal SR, Burroughs M, Frace M, et al. In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins. Antimicrob Agents Chemother. 2014 Nov;58(11):6986-9. PubMed PMID: 25199775; PubMed Central PMCID: PMC4249396.

Watkins ER, Grad YH, Gupta S, Buckee CO. Contrasting within- and between-host immune selection shapes Neisseria Opa repertoires. Sci Rep. 2014 Oct 9;4:6554. PubMed PMID: 25296566.

Grad YH, Newman R, Zody M, Yang X, Murphy R, et al. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. J Virol. 2014 Jul;88(13):7286-93. PubMed PMID: 24741088; PubMed Central PMCID: PMC4054443.

Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis. 2014 Mar;14(3):220-6. PubMed PMID: 24462211; PubMed Central PMCID: PMC4030102.

Grad YH, Waldor MK. Deciphering the origins and tracking the evolution of cholera epidemics with whole-genome-based molecular epidemiology. MBio. 2013 Sep 10;4(5):e00670-13. PubMed PMID: 24023387; PubMed Central PMCID: PMC3774194.

Croucher NJ, Harris SR, Grad YH, Hanage WP. Bacterial genomes in epidemiology–present and future. Philos Trans R Soc Lond B Biol Sci. 2013 Mar 19;368(1614):20120202. PubMed PMID: 23382424; PubMed Central PMCID: PMC3678326.

Wei K, Vaidya A, Rohloff P, Sun YP, Grad Y. Interactive medical case. A patient with fevers and fatigue. N Engl J Med. 2013 Feb 14;368(7):e9. PubMed PMID: 23406050.

Grad YH, Godfrey P, Cerquiera GC, Mariani-Kurkdjian P, Gouali M, et al. Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen. MBio. 2013 Jan 22;4(1):e00452-12. PubMed PMID: 23341549; PubMed Central PMCID: PMC3551546.

Grad YH, Lipsitch M, Griggs AD, Haas BJ, Shea TP, et al. Reply to Guy et al.: Support for a bottleneck in the 2011 Escherichia coli O104:H4 outbreak in Germany. Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3629-30. PubMed PMID: 23479789; PubMed Central PMCID: PMC3535640.

Grad YH, Miller JC, Lipsitch M. Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions. Epidemiology. 2012 Jul;23(4):523-30. PubMed PMID: 22659546; PubMed Central PMCID: PMC3380087.

Grad YH, Lipsitch M, Feldgarden M, Arachchi HM, Cerqueira GC, et al. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3065-70. PubMed PMID: 22315421; PubMed Central PMCID: PMC3286951.

Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012 Jan 1;175(1):54-9. PubMed PMID: 22085628; PubMed Central PMCID: PMC3244610.

Grad YH, Seifter JL, Levy BD, Loscalzo J. Clinical problem-solving. Bitter pills. N Engl J Med. 2010 Nov 4;363(19):1847-51. PubMed PMID: 21047229; PubMed Central PMCID: PMC4098700.

Schaffer AC, Grad Y, Ross JJ. Interactive medical case. Bitter pills. N Engl J Med. 2010 Oct 14;363(16):e26. PubMed PMID: 20942662.